Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10073	Companies
205952	Keywords
136214	Articles
109203	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 04/08/2024 at 23:00, 1 year 11 months ago

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
Biophytis launches OBA phase 2 clinical study with BIO101 (20-hydroxyecdysone) for obesity treatment, targeting muscle preservation and promising results. Clinical program expected to start mid-2024

Biophytis Obesity Treatment BIO101 OBA Phase 2 Muscle Preservation
PRESS RELEASE

published on 04/08/2024 at 23:00, 1 year 11 months ago

Biophytis lance l'étude clinique de phase 2 OBA dans l'obésité avec BIO101 (20-hydroxyecdysone)
Biophytis lance l'étude clinique de phase 2 OBA dans l'obésité avec BIO101 (20-hydroxyecdysone). Résultats prometteurs pour traiter la perte musculaire liée à l'obésité. Marché potentiel de 100 milliards de dollars d'ici 2030

Biophytis Étude Clinique BIO101 Obésité Perte Musculaire
BRIEF

published on 04/04/2024 at 23:05, 1 year 11 months ago

Biophytis annonce le succès de son Assemblée Générale du 2 avril 2024

Biophytis Biotechnologie Assemblée Générale Développement Clinique Maladies Liées À L'âge
BRIEF

published on 04/04/2024 at 23:05, 1 year 11 months ago

Biophytis Announces Unanimous Approval in General Meeting

Biophytis Shareholder Approval General Meeting RuvembriTM Age-related Diseases
PRESS RELEASE

published on 04/04/2024 at 23:00, 1 year 11 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
Biophytis announces all resolutions presented at the combined general meeting on April 2, 2024, have been adopted, including financial delegations. Shareholders' mobilization ensured a quorum of nearly 30%

Shareholders Biophytis General Meeting Resolutions Approval
PRESS RELEASE

published on 04/04/2024 at 23:00, 1 year 11 months ago

RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 2 AVRIL 2024
Biophytis annonce l'adoption de toutes les résolutions lors de son Assemblée Générale Mixte du 2 avril 2024. Les résultats sont disponibles sur leur site. Détails sur les activités et avertissement inclus

Biophytis Développement Biotechnologie Assemblée Générale Résultats
REGULATED PRESS RELEASE

published on 04/04/2024 at 23:00, 1 year 11 months ago

RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 2 AVRIL 2024
Biophytis annonce l'approbation de toutes les résolutions présentées lors de son Assemblée Générale Mixte. Les détails des votes sont disponibles en ligne. En savoir plus sur BIOPHYTIS et ses candidats-médicaments

Biophytis Développement Assemblée Générale Resolutions Candidats-médicaments
REGULATED PRESS RELEASE

published on 04/04/2024 at 23:00, 1 year 11 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
Biophytis announces approval of all resolutions at the Combined General Meeting held on April 2, 2024, with significant shareholder turnout. The Company specializes in therapeutics for age-related diseases

Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
BRIEF

published on 03/22/2024 at 07:05, 2 years ago

Biophytis dévoile son étude de phase 3 sur le traitement de la sarcopénie

Biophytis Sarcopénie Ruvembri Étude De Phase 3 ICFSR
BRIEF

published on 03/22/2024 at 07:05, 2 years ago

Biophytis Unveils Phase 3 Sarcopenia Treatment Protocol

Biophytis Clinical Research RuvembriTM Sarcopenia Phase 3 Study

Accesswire

Published on 03/24/2026 at 10:10, 33 minutes ago

BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Published on 03/24/2026 at 08:01, 2 hours 42 minutes ago

Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 3 hours 43 minutes ago

Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 3 hours 43 minutes ago

Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 00:55, 9 hours 48 minutes ago

BTU Closes Oversubscribed Financing

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 10:36, 7 minutes ago

Original-Research: init innovation in traffic systems SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 03/24/2026 at 10:15, 28 minutes ago

EQS-Adhoc: hep global GmbH invites the bondholders of the Green Bond 2021/2026 (DE000A3H3JV5) to a voting without a meeting regarding an extension of the bond’s term under modified conditions
Published on 03/24/2026 at 10:05, 38 minutes ago

Chaucer and Ceto launch Lloyd's marine MGA, integrating real-time vessel data into underwriting
Published on 03/24/2026 at 10:00, 43 minutes ago

MIG Capital Continues Successful Course in 2025 Despite a Challenging Market Environment
Published on 03/24/2026 at 10:00, 43 minutes ago

Best of m:access 2026: Opportunities for investors in the small and mid-cap segment

Les Echos

Published on 03/24/2026 at 07:45, 2 hours 58 minutes ago

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 2 hours 58 minutes ago

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 3 hours 13 minutes ago

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
Published on 03/24/2026 at 07:30, 3 hours 13 minutes ago

Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities
Published on 03/23/2026 at 19:08, 15 hours 35 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026

View all LES ECHOS COMFI WIRE